The impact of frontline risk-adapted strategy on the overall survival of patients with newly diagnosed multiple myeloma
European Journal of Haematology, 05/07/2012
Tan D et al. – Frontline use of bortezomib in a risk–adapted manner may avert early mortality and is better able to overcome adverse risks compared to its sequential use.



